Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Splenectomy for hematologic disorders: a 20 year experience.

R A Hoefer1, D C Scullin, L F Silver

  • 1Department of Surgery, Baptist Hospital East, Louisville, KY.

The Journal of the Kentucky Medical Association
|September 11, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A multi-institutional analysis of intraoperative radiotherapy for early breast cancer: Does age matter?

American journal of surgery·2017
Same author

Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research Network.

Cancer investigation·2001
Same author

Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma.

Blood·2000
Same author

Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer.

Seminars in oncology·2000
Same author

Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.

Cancer·1999
Same author

Perforation of a Meckel's diverticulum caused by ingestion of a coin.

Southern medical journal·1994

Splenectomy for hematologic disorders is safe in community hospitals, with low morbidity and mortality rates. Larger spleens correlate with increased blood loss, but surgical techniques like splenic bed drainage do not impact outcomes.

Area of Science:

  • Surgical Oncology
  • Hematology

Background:

  • Splenectomy is a common surgical procedure for various hematologic disorders.
  • Understanding surgical outcomes and associated factors is crucial for patient care.

Purpose of the Study:

  • To evaluate the safety and outcomes of splenectomy for hematologic disorders in a community hospital setting.
  • To identify factors influencing morbidity and mortality in splenectomy patients.

Main Methods:

  • Retrospective chart analysis of 59 patients undergoing splenectomy for hematologic disorders between 1970 and 1989.
  • Evaluation of disease entities, indications, splenic weight, blood loss, surgical technique, and drainage.

Main Results:

  • A strong correlation was found between splenic weight and the specific hematologic disorder.

Related Experiment Videos

  • Larger spleens were associated with increased estimated blood loss during surgery.
  • Splenic bed drainage did not affect postoperative bleeding or abscess formation.

    • Conclusions:

    • Splenectomy for hematologic disorders can be performed safely in community hospitals.
    • The observed low morbidity (22%) and mortality (3.4%) rates are comparable to published data.
    • Surgical factors such as splenic weight and blood loss require careful consideration during splenectomy.